Fundraising FoxImmunoRx Pharma
Wilmington, US · Founded 2020 · Delaware corporation · 1 known investors
Find your way into ImmunoRx Pharma
Sign up to find every way you can get introduced to ImmunoRx Pharma
- Your email: who you already know at ImmunoRx Pharma, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ImmunoRx Pharma team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
CF
Caroline FortierNamed on SEC filing
MC
Mark CiprianoNamed on SEC filing
MR
Marc RiviereNamed on SEC filing
PT
Philippe TessierNamed on SEC filing
AL
Alexandre LebeautNamed on SEC filing
Investors · 1
TVM Life Science Innovation SCSpreportedSenningerberg
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$2.7M disclosed across 1 round · 2020
▶$2.7MraisedFeb 2021 · 2 investors · PharmaceuticalsRule 506(b)
▶$2.7MraisedFeb 2021 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Caroline FortierExecutive Officer
- Mark CiprianoExecutive Officer
- Marc RiviereDirector
- Philippe TessierDirector
- Alexandre LebeautDirector
- Offering amount
- $25.4M
- Amount sold
- $2.7M
- Proceeds to insiders
- $86K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are ImmunoRx Pharma's investors?
- ImmunoRx Pharma's investors include TVM Life Science Innovation SCSp.
- How much funding has ImmunoRx Pharma raised?
- ImmunoRx Pharma has disclosed $2.7M raised across 1 round.
- Where is ImmunoRx Pharma headquartered?
- ImmunoRx Pharma is headquartered in Wilmington, US.